Literature DB >> 28170220

Classics in Chemical Neuroscience: Haloperidol.

Marshall W Tyler1, Josefa Zaldivar-Diez1,2, Stephen J Haggarty1.   

Abstract

The discovery of haloperidol catalyzed a breakthrough in our understanding of the biochemical basis of schizophrenia, improved the treatment of psychosis, and facilitated deinstitutionalization. In doing so, it solidified the role for chemical neuroscience as a means to elucidate the molecular underpinnings of complex neuropsychiatric disorders. In this Review, we will cover aspects of haloperidol's synthesis, manufacturing, metabolism, pharmacology, approved and off-label indications, and adverse effects. We will also convey the fascinating history of this classic molecule and the influence that it has had on the evolution of neuropsychopharmacology and neuroscience.

Entities:  

Keywords:  Haloperidol; antipsychotic; dopamine; history; pharmacology; schizophrenia

Mesh:

Substances:

Year:  2017        PMID: 28170220     DOI: 10.1021/acschemneuro.7b00018

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  15 in total

1.  DOPA Decarboxylase Modulates Tau Toxicity.

Authors:  Rebecca L Kow; Carl Sikkema; Jeanna M Wheeler; Charles W Wilkinson; Brian C Kraemer
Journal:  Biol Psychiatry       Date:  2017-06-15       Impact factor: 13.382

Review 2.  Schizophrenia: synthetic strategies and recent advances in drug design.

Authors:  Maria Azmanova; Anaïs Pitto-Barry; Nicolas P E Barry
Journal:  Medchemcomm       Date:  2018-03-16       Impact factor: 3.597

3.  Striatal transcriptome changes linked to drug-induced repetitive behaviors.

Authors:  Jill R Crittenden; Theresa A Gipson; Anne C Smith; Hilary A Bowden; Ferah Yildirim; Kyle B Fischer; Michael Yim; David E Housman; Ann M Graybiel
Journal:  Eur J Neurosci       Date:  2021-03-23       Impact factor: 3.386

4.  Site-selective, catalytic, and diastereoselective sp3 C-H hydroxylation and alkoxylation of vicinally functionalized lactams.

Authors:  Timothy K Beng; Victoria Shearer; Rachel Davey; Ivianne Redman
Journal:  RSC Adv       Date:  2020-05-27       Impact factor: 4.036

5.  Ubiquitin-proteasome system, lipid metabolism and DNA damage repair are triggered by antipsychotic medication in human oligodendrocytes: implications in schizophrenia.

Authors:  Gabriela Seabra; Valéria de Almeida; Guilherme Reis-de-Oliveira; Fernanda Crunfli; André Saraiva Leão Marcelo Antunes; Daniel Martins-de-Souza
Journal:  Sci Rep       Date:  2020-07-28       Impact factor: 4.379

6.  Impact of Sleep-Wake-Associated Neuromodulators and Repetitive Low-Frequency Stimulation on Human iPSC-Derived Neurons.

Authors:  Remi Yokoi; Miho Okabe; Naoki Matsuda; Aoi Odawara; Akihiro Karashima; Ikuro Suzuki
Journal:  Front Neurosci       Date:  2019-05-29       Impact factor: 4.677

7.  Effect of Dopamine D2 Receptor Antagonists on [18F]-FEOBV Binding.

Authors:  Anna Schildt; Erik F J de Vries; Antoon T M Willemsen; Bruno Lima Giacobbo; Rodrigo Moraga-Amaro; Jürgen W A Sijbesma; Aren van Waarde; Vesna Sossi; Rudi A J O Dierckx; Janine Doorduin
Journal:  Mol Pharm       Date:  2020-02-17       Impact factor: 4.939

8.  Non-ketotic Hyperglycemia Chorea-Ballismus and Intracerebral Hemorrhage: A Case Report and Literature Review.

Authors:  Mingming Dong; Jian-Yu E; Liyang Zhang; Weiyu Teng; Li Tian
Journal:  Front Neurosci       Date:  2021-06-23       Impact factor: 4.677

9.  A quantum chemical approach representing a new perspective concerning agonist and antagonist drugs in the context of schizophrenia and Parkinson's disease.

Authors:  Ana Martínez; Ilich A Ibarra; Rubicelia Vargas
Journal:  PLoS One       Date:  2019-12-12       Impact factor: 3.240

10.  Design, Synthesis and Biological Investigation of Flavone Derivatives as Potential Multi-Receptor Atypical Antipsychotics.

Authors:  Lanchang Gao; Zhengge Yang; Jiaying Xiong; Chao Hao; Ru Ma; Xin Liu; Bi-Feng Liu; Jian Jin; Guisen Zhang; Yin Chen
Journal:  Molecules       Date:  2020-09-08       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.